Merit Financial Group’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$691K Sell
10,263
-1,251
-11% -$83.3K ﹤0.01% 1301
2026
Q1
$723K Sell
11,514
-865
-7% -$60.2K 0.01% 1152
2025
Q4
$822K Buy
12,379
+6,415
+108% +$415K 0.01% 1031
2025
Q3
$401K Sell
5,964
-490
-8% -$38.8K ﹤0.01% 1301
2025
Q2
$563K Buy
6,454
+521
+9% +$40.8K 0.01% 1046
2025
Q1
$405K Buy
5,933
+3,000
+102% +$245K 0.01% 1022
2024
Q4
$228K Buy
+2,933
New +$217K ﹤0.01% 1044
2024
Q2
Sell
-1,627
Closed -$209K 922
2024
Q1
$209K Buy
+1,627
New +$205K 0.01% 805

Other funds holding DXCM

Merit Financial Group's DXCM Position: Q2 2026 in Review

Merit Financial Group reduced its DexCom (DXCM) stake by 11% in Q2 2026, selling an estimated $83.3K and leaving 10,263 shares worth $691K. The position accounts for ﹤0.01% of the portfolio, ranked #1301.

Merit Financial Group first reported a position in DXCM in Q1 2024 and has held it in 8 quarters since. The position peaked at $822K in Q4 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Merit Financial Group held 10,263 shares of DexCom worth $691K as of Q2 2026.
  • Merit Financial Group sold 1,251 DexCom shares in Q2 2026, an estimated $83.3K.
  • DexCom made up ﹤0.01% of Merit Financial Group's portfolio in Q2 2026, its #1301 holding.
  • Merit Financial Group first reported a position in DexCom in Q1 2024 and has held it in 8 quarters since.
  • Merit Financial Group's DexCom position peaked at $822K in Q4 2025.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.